Navigation Links
FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
Date:4/29/2010

Dendreon will donate funds to an independent non-profit organization that will provide financial assistance to patients who cannot afford the co-payments associated with their prostate cancer medicines. In addition, Dendreon's dedicated call center case managers will proactively help match patients with foundations to support their financial assistance needs.  

For more information, please visit www.PROVENGE.com.

Conference Call Information

Please be advised that Dendreon will not be hosting a first quarter financial results call.  

To access the live conference call, dial 1-866-788-0546 (domestic) or 857-350-1684 (international) participant passcode: 35405823. The call also will be audio webcast and will be available from the Company's website at www.dendreon.com under the "Investor/Webcasts and Presentations" section. There will be a slide presentation to accompany the call, which will also be available on this section of the Dendreon website. A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 888-286-8010 or 617-801-6888 (international); the participant pass code is 18379189. The replay will be available from April, 29 at 9:00 p.m. ET until May 13 at 11:59 p.m. ET. In addition, the webcast will be archived for on-demand listening for
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... market for Fluoroscopy is expected to grow at a ... is used to view the gastrointestinal tract, to direct ... ducts or the urinary system, to open narrowed or ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ) has ... - Global Strategic Business Report" report to ... are provided for the period 2014 through 2020. ... these markets. Market data and analytics are derived ... primarily based on public domain information including company ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2
... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ ... ingredients (APIs), announced that its,Tainan facility has received ... The Certification confirms ScinoPharm,s,competency and proficiency in the ... applies to specific laboratories and,production areas used for ...
... , CAMBRIDGE, Mass., Nov. 19 Ligon ... to find drugs against high-value targets, today announced that ... incTANK Ventures. The company will use the capital to ... 100 high-value disease protein targets. With this investment, incTANK ...
Cached Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3
(Date:6/2/2015)... Island, N.Y. (PRWEB) June 02, 2015 ... refer to computer generated imagery overlaid on the real ... gone but Vein Visualization, which displays a map of ... shown a steady growth in adoption. , AccuVein, the ... 40% year over year growth rate and such widespread ...
(Date:6/2/2015)... India (PRWEB) June 02, 2015 Bitscape ... in the 2015 Microsoft Worldwide Small and Midsized Cloud ... field of top Microsoft partners for demonstrating excellence in ... technology. , “This comes as no surprise to ... recognized third year consecutively at worldwide level by Microsoft. ...
(Date:6/2/2015)... Washington, DC (PRWEB) June 02, 2015 Did ... you’re wondering what to get him, his family isn’t asking ... Renegades , the team walking in Saturday’s Cure HHT DC ... a genetic disease that causes malformed blood vessels leading to ... began to appear when Ryder was 3 years old ...
(Date:6/2/2015)... On October 1, 2015 the transition to ... , On Monday, June 1st Congressman Kevin ... Ways and Means Committee, and 12 members of the ... Medicaid Services, urging the administration to provide a smooth ... ICD-10 is the newest coding system for healthcare professionals ...
(Date:6/2/2015)... 2015 ANT Wireless, proven innovator in ... of two new products implementing the ANT+ Fitness Equipment ... wireless interoperability in their bike trainer products, built to ... has implemented the FE-C device profile in its Vortex ... its new indoor training software, while Kinomap has added ...
Breaking Medicine News(10 mins):Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3
... the electromagnetic radiation research center feel, that we ... low level radiowaves. Radiowaves and microwaves play an increasing ... computers and personal digital assistants, pagers, and text messengers. ... unaware of their existence. In other words, we are ...
... research shows people with diabetes who are in a ... their unhappily married counterparts. Researchers from the State University ... 70 adults with diabetes who had been married for ... on insulin, were surveyed again two years after the ...
... Atmospheric pollution affects the normal breathing functions. Exposure to ... muscle during exercise in those with heart problems. There ... with both heart disease and lung problems.But a study ... pollution can restrict the oxygen supply to the heart ...
... who eat lots of fruit and vegetables are less ... cent of those with chronic obstructive pulmonary disease (COPD) ... smokers// actually develop COPD - so there must be ... or environmental. ,Researchers at the University of ...
... those who consume wine in moderation have healthier lifestyles overall ... It is well established that moderate alcohol consumption seems ... reduced risk of heart disease. A new study shows that ... factors that produce at least some of the beneficial effects. ...
... the power of a common heart medication in reducing the ... not take the medications. Research shows the use of beta-blocker ... early death by 20 percent. However, many patients fear side ... do not take the drugs. A new study finds there ...
Cached Medicine News:
... The AQT-10 is the ultimate in ... designed to detect the subtle red/green or ... disorders as retinal toxicity (that from Plaquenil, ... retinopathy, and macular degeneration. Additionally it is ...
... Amplifier (UBA-4204) from LKC Technologies, ... amplification and complete electrical isolation ... problems of DC drifting, 50/60Hz ... make the amplifier ideal for ...
... PACHETT 3 uses the exact enhanced corneal ... DGH pachymeters used exclusively by the OHTS ... into the software. The new backlit LCD ... average, standard deviation and IOP correction calculation ...
Orbital Retractor, schepens Retractors, overall length:154mm....
Medicine Products: